Does FOLLITROPIN Cause Choroidal neovascularisation? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Choroidal neovascularisation have been filed in association with FOLLITROPIN (Gonal-f RFF Redi-ject). This represents 0.2% of all adverse event reports for FOLLITROPIN.
6
Reports of Choroidal neovascularisation with FOLLITROPIN
0.2%
of all FOLLITROPIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Choroidal neovascularisation From FOLLITROPIN?
Of the 6 reports.
Is Choroidal neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOLLITROPIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FOLLITROPIN Cause?
Ovarian hyperstimulation syndrome (718)
Ascites (213)
No adverse event (213)
Abdominal distension (154)
Headache (151)
Nausea (129)
Abdominal pain (115)
Product quality issue (111)
Abortion spontaneous (102)
Dyspnoea (101)
What Other Drugs Cause Choroidal neovascularisation?
RANIBIZUMAB (195)
PEGCETACOPLAN (52)
AFLIBERCEPT (47)
VERTEPORFIN (47)
BEVACIZUMAB (38)
BROLUCIZUMAB-DBLL (38)
PENTOSAN POLYSULFATE (17)
PREDNISONE (10)
SILDENAFIL (10)
LUCENTIS (9)
Which FOLLITROPIN Alternatives Have Lower Choroidal neovascularisation Risk?
FOLLITROPIN vs FOLLITROPIN ALFA
FOLLITROPIN vs FOLLITROPIN BETA
FOLLITROPIN vs FOLLITROPIN\LUTEINIZING HORMONE
FOLLITROPIN vs FOLLITROPIN\LUTROPIN ALFA
FOLLITROPIN vs FONDAPARINUX